Literature DB >> 6597687

The prophylactic use of flurbiprofen to prevent post-extraction dental pain.

J A Giglio, R L Campbell.   

Abstract

This study was designed to evaluate the effectiveness of flurbiprofen when compared to aspirin and placebo. The study medications were administered 30 minutes preoperatively and at fixed intervals four and eight hours later in 107 patients undergoing surgical removal of third molars using a randomized, double-blind design. The treatment consisted of flurbiprofen 25mg, flurbiprofen 50mg, aspirin 650mg, and placebo. Flurbiprofen was significantly more effective than aspirin and placebo with respect to pain severity scores and patient evaluation of the pretreatment dose. Aspirin was significantly more effective than placebo. There were no differences between the two doses of flurbiprofen. Side effects were minor and not significantly different among the groups.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6597687      PMCID: PMC2515535     

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  2 in total

1.  Evaluation of preoperative ibuprofen for postoperative pain after removal of third molars.

Authors:  R A Dionne; S A Cooper
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1978-06

2.  Suppression of postoperative pain by preoperative administration of ibuprofen in comparison to placebo, acetaminophen, and acetaminophen plus codeine.

Authors:  R A Dionne; R A Campbell; S A Cooper; D L Hall; B Buckingham
Journal:  J Clin Pharmacol       Date:  1983-01       Impact factor: 3.126

  2 in total
  3 in total

1.  Endogenous monoamine analgesic systems: amitriptyline in painful diabetic neuropathy.

Authors:  M B Max
Journal:  Anesth Prog       Date:  1987-07

Review 2.  The scientific basis for analgesic use in dentistry.

Authors:  E S Troullos; R D Freeman; R A Dionne
Journal:  Anesth Prog       Date:  1986 May-Jun

Review 3.  Single dose oral aspirin for acute postoperative pain in adults.

Authors:  Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.